Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
Authors
Keywords
Cardiac hypertrophy, Cytokines, Cardiomyocytes, Transcription factors, Small interfering RNA, Heart, Apoptosis, Atrial natriuretic peptide
Journal
PLOS BIOLOGY
Volume 18, Issue 12, Pages e3000967
Publisher
Public Library of Science (PLoS)
Online
2020-12-04
DOI
10.1371/journal.pbio.3000967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure
- (2018) Ling Zhou et al. CIRCULATION
- AMPKα2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation
- (2017) Bei Wang et al. CIRCULATION RESEARCH
- MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial TranslationClinical Perspective
- (2016) Huaping Li et al. CIRCULATION
- Substance P induces cardioprotection in ischemia-reperfusion via activation of AKT
- (2015) Shaiban Jubair et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Lacidipine attenuates TNF-α-induced cardiomyocyte apoptosis
- (2015) Qiu-Lin Wang et al. CYTOKINE
- Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts
- (2015) Feng Su et al. LABORATORY INVESTIGATION
- Transmembrane tumor necrosis factor-alpha sensitizes adipocytes to insulin
- (2015) Wenjing Zhou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy
- (2014) Courtney Moc et al. CARDIOVASCULAR RESEARCH
- Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth
- (2013) Mingxia Yu et al. CANCER RESEARCH
- Therapeutic Potential of Tumour Necrosis Factor-alpha Antagonists in Patients with Chronic Heart Failure
- (2013) Qamar Javed et al. Heart Lung and Circulation
- TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis
- (2013) Clemens Duerrschmid et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Tumor Necrosis Factor-α and Lymphotoxin-α Mediate Myocardial Ischemic Injury via TNF Receptor 1, but Are Cardioprotective When Activating TNF Receptor 2
- (2013) Yanqing Zhang et al. PLoS One
- Tumor necrosis factor receptor cross-talk
- (2011) Petrus J. W. Naudé et al. FEBS Journal
- The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity
- (2011) Hui Chen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Divergent Tumor Necrosis Factor Receptor–Related Remodeling Responses in Heart Failure
- (2009) Tariq Hamid et al. CIRCULATION
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Transmembrane TNF-α mediates “forward” and “reverse” signaling, inducing cell death or survival via the NF-κB pathway in Raji Burkitt lymphoma cells
- (2008) Hailong Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The role of TNF-α receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning
- (2008) Michael P. Flaherty et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Blockade of NF-κB Using IκBα Dominant-Negative Mice Ameliorates Cardiac Hypertrophy in Myotrophin-Overexpressed Transgenic Mice
- (2008) David Young et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More